263 related articles for article (PubMed ID: 38781120)
1. Mitotic deacetylase complex (MiDAC) recognizes the HIV-1 core promoter to control activated viral gene expression.
Wilhelm E; Poirier M; Da Rocha M; Bédard M; McDonald PP; Lavigne P; Hunter CL; Bell B
PLoS Pathog; 2024 May; 20(5):e1011821. PubMed ID: 38781120
[TBL] [Abstract][Full Text] [Related]
2. CTGC motifs within the HIV core promoter specify Tat-responsive pre-initiation complexes.
Wilhelm E; Doyle MC; Nzaramba I; Magdzinski A; Dumais N; Bell B
Retrovirology; 2012 Jul; 9():62. PubMed ID: 22834489
[TBL] [Abstract][Full Text] [Related]
3. Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-κB/Sp1/Tat Circuitry.
Welch JL; Kaddour H; Schlievert PM; Stapleton JT; Okeoma CM
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111566
[TBL] [Abstract][Full Text] [Related]
4. Splicing Factor 3B Subunit 1 Interacts with HIV Tat and Plays a Role in Viral Transcription and Reactivation from Latency.
Kyei GB; Meng S; Ramani R; Niu A; Lagisetti C; Webb TR; Ratner L
mBio; 2018 Nov; 9(6):. PubMed ID: 30401776
[TBL] [Abstract][Full Text] [Related]
5. A Stronger Transcription Regulatory Circuit of HIV-1C Drives the Rapid Establishment of Latency with Implications for the Direct Involvement of Tat.
Chakraborty S; Kabi M; Ranga U
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669338
[TBL] [Abstract][Full Text] [Related]
6. The Molecular Basis for Human Immunodeficiency Virus Latency.
Mbonye U; Karn J
Annu Rev Virol; 2017 Sep; 4(1):261-285. PubMed ID: 28715973
[TBL] [Abstract][Full Text] [Related]
7. Selective recognition of viral promoters by host cell transcription complexes: challenges and opportunities to control latency.
Wilhelm E; Bell B
Curr Opin Virol; 2013 Aug; 3(4):380-6. PubMed ID: 23827503
[TBL] [Abstract][Full Text] [Related]
8. HIV latency reversing agents act through Tat post translational modifications.
Khoury G; Mota TM; Li S; Tumpach C; Lee MY; Jacobson J; Harty L; Anderson JL; Lewin SR; Purcell DFJ
Retrovirology; 2018 May; 15(1):36. PubMed ID: 29751762
[TBL] [Abstract][Full Text] [Related]
9. A chalcone derivative reactivates latent HIV-1 transcription through activating P-TEFb and promoting Tat-SEC interaction on viral promoter.
Wu J; Ao MT; Shao R; Wang HR; Yu D; Fang MJ; Gao X; Wu Z; Zhou Q; Xue YH
Sci Rep; 2017 Sep; 7(1):10657. PubMed ID: 28878233
[TBL] [Abstract][Full Text] [Related]
10. Transition step during assembly of HIV Tat:P-TEFb transcription complexes and transfer to TAR RNA.
D'Orso I; Jang GM; Pastuszak AW; Faust TB; Quezada E; Booth DS; Frankel AD
Mol Cell Biol; 2012 Dec; 32(23):4780-93. PubMed ID: 23007159
[TBL] [Abstract][Full Text] [Related]
11. Probabilistic control of HIV latency and transactivation by the Tat gene circuit.
Cao Y; Lei X; Ribeiro RM; Perelson AS; Liang J
Proc Natl Acad Sci U S A; 2018 Dec; 115(49):12453-12458. PubMed ID: 30455316
[TBL] [Abstract][Full Text] [Related]
12. Role of Host Factors on the Regulation of Tat-Mediated HIV-1 Transcription.
Mousseau G; Valente ST
Curr Pharm Des; 2017; 23(28):4079-4090. PubMed ID: 28641539
[TBL] [Abstract][Full Text] [Related]
13. HEXIM1-Tat chimera inhibits HIV-1 replication.
Leoz M; Kukanja P; Luo Z; Huang F; Cary DC; Peterlin BM; Fujinaga K
PLoS Pathog; 2018 Nov; 14(11):e1007402. PubMed ID: 30395647
[TBL] [Abstract][Full Text] [Related]
14. UHRF1 Suppresses HIV-1 Transcription and Promotes HIV-1 Latency by Competing with p-TEFb for Ubiquitination-Proteasomal Degradation of Tat.
Liang T; Zhang Q; Wu Z; Chen P; Huang Y; Liu S; Li L
mBio; 2021 Aug; 12(4):e0162521. PubMed ID: 34465029
[TBL] [Abstract][Full Text] [Related]
15. An emerging and variant viral promoter of HIV-1 subtype C exhibits low-level gene expression noise.
Ali H; Bhange D; Mehta K; Gohil Y; Prajapati HK; Byrareddy SN; Buch S; Ranga U
Retrovirology; 2021 Sep; 18(1):27. PubMed ID: 34538278
[TBL] [Abstract][Full Text] [Related]
16. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
[TBL] [Abstract][Full Text] [Related]
17. BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.
Boehm D; Calvanese V; Dar RD; Xing S; Schroeder S; Martins L; Aull K; Li PC; Planelles V; Bradner JE; Zhou MM; Siliciano RF; Weinberger L; Verdin E; Ott M
Cell Cycle; 2013 Feb; 12(3):452-62. PubMed ID: 23255218
[TBL] [Abstract][Full Text] [Related]
18. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.
Williams SA; Chen LF; Kwon H; Ruiz-Jarabo CM; Verdin E; Greene WC
EMBO J; 2006 Jan; 25(1):139-49. PubMed ID: 16319923
[TBL] [Abstract][Full Text] [Related]
19. HMGA1 directly interacts with TAR to modulate basal and Tat-dependent HIV transcription.
Eilebrecht S; Wilhelm E; Benecke BJ; Bell B; Benecke AG
RNA Biol; 2013 Mar; 10(3):436-44. PubMed ID: 23392246
[TBL] [Abstract][Full Text] [Related]
20. The Tat/P-TEFb Protein-Protein Interaction Determining Transcriptional Activation of HIV.
Asamitsu K; Okamoto T
Curr Pharm Des; 2017; 23(28):4091-4097. PubMed ID: 28699519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
